Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-06-10

Arbutus Biopharma (ABUS)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$3,578,150
Michael McElhaugh total, FY2025
CEO pay percentile vs peers
CEO-to-median pay ratio
94.29%
Say-on-pay support, latest vote
Companies that benchmark against ABUS
4 companies name ABUS as a compensation peer

Each company listed discloses ABUS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ABUS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Michael McElhaugh$109,658$0$582,330$1,855,495$0$0$1,030,667$3,578,150
Former Interim President and Chief Executive Officer
Tuan Nguyen359,849001,879,890159,756017,5002,416,995
Chief Financial Officer
David Hastings138,6130296,429944,26800839,0522,218,362
Former Chief Financial Officer
Lindsay Androski437,75000714,751216,512001,369,013
President and Chief Executive Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Michael McElhaugh$3,578,150
Tuan Nguyen2,416,995
David Hastings2,218,362
Lindsay Androski1,369,013

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Roger SawhneyDirector2026-06-08A78,800$0$0Derivative, Class A CommonForm 4 ↗
Robert Alan BeardsleyDirector2026-06-08A78,80000Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
David HastingsOPTION$944,268
Michael McElhaughOPTION1,855,495
Lindsay AndroskiOPTION714,751
David HastingsRSU296,429
Michael McElhaughRSU582,330
Tuan NguyenOPTION1,879,890
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
David Hastings$296,429$0$944,2680.0%
Michael McElhaugh582,33001,855,4950.0%
Lindsay Androski00714,7510.0%
Tuan Nguyen001,879,8900.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Tuan NguyenOption750,0003.49
Lindsay AndroskiOption310,4223.2
05

Incentive-plan design — the Compensation Discussion & Analysis

Currently, our executive compensation program principally consists of the following components: base salary, annual incentive cash bonus, long-term incentives in the form of stock options and restricted stock units, and health and retirement benefits generally available to all our employees.

CEO STI target (% of salary)45%
CEO LTI target (% of salary)
Independent consultantRadford
Clawback policytrue
Anti-hedging
Anti-pledging
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-26137,629,2078,331,760512,66094.29%Passed
20252025-05-21122,791,7496,976,561347,54794.62%Passed
20242024-05-2299,284,55713,548,3189,771,54887.99%Passed
20232023-05-2485,552,3038,211,1961,055,98391.24%Passed
20222022-05-2571,034,9115,946,818461,31092.28%Passed
20212021-05-2634,997,4092,754,917368,08992.7%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-2694.29%a
20252025-05-2194.62%b
20242024-05-2287.99%c

a. Approved under the standard stated in the filing — “Broker non-votes and abstentions will have no effect on the outcome of this Proposal No.”.

b. Approved under the standard stated in the filing — “Broker non-votes and abstentions will have no effect on the outcome of this Proposal No.”.

c. Approved under the standard stated in the filing — “" Broker non-votes and abstentions will have no effect on the outcome of this Proposal No.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)
CEO total compensation
Median employee compensation
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Robert Alan BeardsleyIndependent · Audit · Compensation (Chair)$55,098$0$362,876$0$0$417,974
Roger SawhneyIndependent · Audit · Corporate Governance and Nominating22,5590365,40200387,961
Anuj HasijaIndependent · Departed during FY24,2770362,87600387,153
Frank TortiIndependent · Departed during FY12,56800012,568
James MeyersIndependent · Departed during FY10,66400010,664
Richard C. HenriquesIndependent · Departed during FY10,28300010,283
Daniel BurgessIndependent · Departed during FY8,379008,379
Keith ManchesterIndependent · Departed during FY7,617007,617
Melissa V. RewolinskiIndependent · Departed during FY7,236007,236
Joseph BishopIndependent · Audit (Chair) · Compensation · Corporate Governance and Nominating000000
Lindsay AndroskiEmployee director · Board Chair00000
Michael J. McElhaughEmployee director · Departed during FY00000
Matthew GlineIndependent · Compensation · Corporate Governance and Nominating000000
09

Board fee structure and ownership guideline

Annual cash retainer$40,000
Annual equity retainer
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)20,000 / 15,000 / 10,000
Stock ownership guideline
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$158,681
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$158,681

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Arbutus Biopharma2025Michael McElhaugh$109,658$582,330$1,855,495$0$3,578,150

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Michael McElhaughDEF 14A2026-04-140001140361-26-014623Section “Summary Compensation Table”. As printed: 3,578,150. Filing ↗machine: t100 · r6 · c24 · span 395795–395804
2Section 01, Tuan NguyenDEF 14A2026-04-140001140361-26-014623Section “Summary Compensation Table”. As printed: 2,416,995. Filing ↗machine: r4 · c24 · span 386623–386632
3Section 01, David HastingsDEF 14A2026-04-140001140361-26-014623Section “Summary Compensation Table”. As printed: 2,218,362. Filing ↗machine: r8 · c24 · span 404825–404834
4Section 01, Lindsay AndroskiDEF 14A2026-04-140001140361-26-014623Section “Summary Compensation Table”. As printed: 1,369,013. Filing ↗machine: t100 · r2 · c24 · span 377494–377503
5Section 03, David Hastings OPTIONDEF 14A2026-04-140001140361-26-014623Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t100 · r8 · c15 · span 403277–403284
6Section 03, Michael McElhaugh OPTIONDEF 14A2026-04-140001140361-26-014623Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t100 · r6 · c15 · span 394049–394058
7Section 03, Lindsay Androski OPTIONDEF 14A2026-04-140001140361-26-014623Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t100 · r2 · c15 · span 375756–375763
8Section 03, David Hastings RSUDEF 14A2026-04-140001140361-26-014623Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t100 · r8 · c12 · span 402758–402765
9Section 03, Michael McElhaugh RSUDEF 14A2026-04-140001140361-26-014623Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t100 · r6 · c12 · span 393484–393491
10Section 03, Tuan Nguyen OPTIONDEF 14A2026-04-140001140361-26-014623Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t100 · r4 · c15 · span 385120–385129
11Section 07, pay ratio10-K2026-03-230001447028-26-000017Section “CEO Pay Ratio”. As printed: —. Filing ↗
12Section 08, Robert Alan BeardsleyDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 417,974. Filing ↗machine: t125 · r2 · c12 · span 680931–680938
13Section 08, Roger SawhneyDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 387,961. Filing ↗machine: t125 · r5 · c12 · span 688248–688255
14Section 08, Anuj HasijaDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 387,153. Filing ↗machine: t125 · r6 · c12 · span 690941–690948
15Section 08, Frank TortiDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 12,568. Filing ↗machine: t125 · r7 · c3 · span 691775–691781
16Section 08, James MeyersDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 10,664. Filing ↗machine: t125 · r11 · c3 · span 701773–701779
17Section 08, Richard C. HenriquesDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 10,283. Filing ↗machine: t125 · r9 · c3 · span 696775–696781
18Section 08, Daniel BurgessDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 8,379. Filing ↗machine: t125 · r8 · c3 · span 694206–694211
19Section 08, Keith ManchesterDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 7,617. Filing ↗machine: t125 · r10 · c3 · span 699212–699217
20Section 08, Melissa V. RewolinskiDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 7,236. Filing ↗machine: t125 · r12 · c3 · span 704272–704277
21Section 08, Joseph BishopDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 0. Filing ↗
22Section 08, Lindsay AndroskiDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 0. Filing ↗
23Section 08, Michael J. McElhaughDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 0. Filing ↗
24Section 08, Matthew GlineDEF 14A2026-04-140001140361-26-014623Section “Director Compensation”. As printed: 0. Filing ↗
25Section 02, Roger Sawhney 2026-06-08Form 42026-06-100001447028-26-000040Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Robert Alan Beardsley 2026-06-08Form 42026-06-100001447028-26-000039Insider equity transaction reported since the proxy statement. Filing ↗
27Section 06, 2026 voteForm 8-K2026-05-270001447028-26-000024Item 5.07 · say-on-pay result. As reported: 94.29% (votes for as printed: 137,629,207). Filing ↗
28Section 06, 2025 voteForm 8-K2025-05-230001447028-25-000104Item 5.07 · say-on-pay result. As reported: 94.62% (votes for as printed: 122,791,749). Filing ↗
29Section 06, 2024 voteForm 8-K2024-05-280001447028-24-000061Item 5.07 · say-on-pay result. As reported: 87.99% (votes for as printed: 99,284,557). Filing ↗
30Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
31Section 09b board cost (computed)ComputedcomputedCash 158,681 + equity 0 + all other 0 = 158,681, summed across the director compensation table rows.machine: formula: Σ = 158,681
32Arbutus Biopharma (subject), Section 10b CEO totalDEF 14A2026-04-140001140361-26-014623CEO total compensation as printed in Arbutus Biopharma's own proxy. As printed: 3,578,150. Filing ↗machine: t100 · r6 · c24 · span 395795–395804